A specific and adaptable approach to track CD206+ macrophages by molecular MRI and fluorescence imaging.
AAV hamartin gene therapy in a stochastic, cerebral mouse model of tuberous sclerosis type 1.
Mol Ther Methods Clin Dev. 2025;33(3):101556 - PMID: 40932991 - PMCID: PMC12419009 - DOI: 10.1016/j.omtm.2025.101556
2
CSV